Federal award
BIOFIRE DIAGNOSTICS LLC
W81K0017P0719
Contract
Obligated and Ceiling
- Obligated (net)
- $467,733.75
- Ceiling (potential value, not spending)
- $665,402.10
- Current value
- $467,733.75
- Gross positive obligations
- $467,733.75
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- BIOFIRE DIAGNOSTICS LLC · TBBNREFT3LD3
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- COMPAGNIE MERIEUX ALLIANCE · PFPLR7Q9VGC8
- Awarding agency
- Department of War · sub-agency 2100 · office W81K00
- Funding agency
- Department of War · sub-agency 2100
- Product or service (PSC)
- 6505 · DRUGS AND BIOLOGICALS
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- W81K0017P0719
- Award type code
- B
- Actions
- 6 · Sep 21, 2017 to Jul 31, 2019
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History6
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Jul 31, 2019 | FY2019 | P00005 | B | $28,947.60 | — |
| Nov 1, 2018 | FY2019 | P00004 | C | $197,668.35 | — |
| Sep 26, 2018 | FY2018 | P00003 | G | $0.00 | — |
| May 10, 2018 | FY2018 | P00002 | C | $43,449.45 | — |
| Nov 3, 2017 | FY2018 | P00001 | C | $197,668.35 | — |
| Sep 21, 2017 | FY2017 | 0 | — | $0.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.